These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30639654)

  • 1. Inhibitory effects of arylcoumarin derivatives on Bacteroides fragilisd‑lactate dehydrogenase.
    Ugurel E; Danis O; Mutlu O; Yuce-Dursun B; Gunduz C; Turgut-Balik D
    Int J Biol Macromol; 2019 Apr; 127():197-203. PubMed ID: 30639654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and evaluation of inhibitory activity and mechanism of arylcoumarin derivatives on Theileria annulata enolase by in vitro and molecular docking studies.
    Yakarsonmez S; Danis O; Mutlu O; Topuzogullari M; Sariyer E; Yuce-Dursun B; Turgut-Balik D
    Mol Divers; 2020 Nov; 24(4):1149-1164. PubMed ID: 31754915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate dehydrogenase activity as a cause of metronidazole resistance in Bacteroides fragilis NCTC 11295.
    Narikawa S; Suzuki T; Yamamoto M; Nakamura M
    J Antimicrob Chemother; 1991 Jul; 28(1):47-53. PubMed ID: 1769942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into the functional and structural properties of 3-arylcoumarin as an interesting scaffold in monoamine oxidase B inhibition.
    Matos MJ; Vilar S; García-Morales V; Tatonetti NP; Uriarte E; Santana L; Viña D
    ChemMedChem; 2014 Jul; 9(7):1488-500. PubMed ID: 24715707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
    Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
    Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
    J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
    Wang G; He D; Li X; Li J; Peng Z
    Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate dehydrogenase activity and metronidazole susceptibility in Bacteroides fragilis.
    Tabaqchali S; Pantosti A; Oldfield S
    J Antimicrob Chemother; 1983 May; 11(5):393-400. PubMed ID: 6874627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coumarin derivatives as promising xanthine oxidase inhibitors.
    Fais A; Era B; Asthana S; Sogos V; Medda R; Santana L; Uriarte E; Matos MJ; Delogu F; Kumar A
    Int J Biol Macromol; 2018 Dec; 120(Pt A):1286-1293. PubMed ID: 30189275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some coumarins and benzoxazinones as potent paraoxonase 1 inhibitors.
    Karataş MO; Uslu H; Alıcı B; Gökçe B; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1386-91. PubMed ID: 26887799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective MAO-B inhibitory activity: amino- versus nitro-3-arylcoumarin derivatives.
    Matos MJ; Rodríguez-Enríquez F; Vilar S; Santana L; Uriarte E; Hripcsak G; Estrada M; Rodríguez-Franco MI; Viña D
    Bioorg Med Chem Lett; 2015 Feb; 25(3):642-8. PubMed ID: 25532905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate dehydrogenase activity in Bacteroides fragilis group strains with induced resistance to metronidazole.
    Presečki Stanko A; Sóki J; Varda Brkić D; Plečko V
    J Glob Antimicrob Resist; 2016 Jun; 5():11-4. PubMed ID: 27436459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAO inhibitory activity of 2-arylbenzofurans versus 3-arylcoumarins: synthesis, in vitro study, and docking calculations.
    Ferino G; Cadoni E; Matos MJ; Quezada E; Uriarte E; Santana L; Vilar S; Tatonetti NP; Yáñez M; Viña D; Picciau C; Serra S; Delogu G
    ChemMedChem; 2013 Jun; 8(6):956-66. PubMed ID: 23589499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid Pharmacophoric Approach in the Design and Synthesis of Coumarin Linked Pyrazolinyl as Urease Inhibitors, Kinetic Mechanism and Molecular Docking.
    Saeed A; Mahesar PA; Channar PA; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
    Chem Biodivers; 2017 Aug; 14(8):. PubMed ID: 28574649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies.
    Karataş MO; Uslu H; Sarı S; Alagöz MA; Karakurt A; Alıcı B; Bilen C; Yavuz E; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Oct; 31(5):760-72. PubMed ID: 26207513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction.
    Sangshetti JN; Kalam Khan FA; Kulkarni AA; Patil RH; Pachpinde AM; Lohar KS; Shinde DB
    Bioorg Med Chem Lett; 2016 Feb; 26(3):829-835. PubMed ID: 26778149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking studies of fused coumarin derivatives as inhibitors of GlcN-6.
    Govori S; Haziri A; Ademi K; Neziraj N
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2017 Sep; 52(11):1041-1045. PubMed ID: 28737449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives.
    Srivastava P; Vyas VK; Variya B; Patel P; Qureshi G; Ghate M
    Bioorg Chem; 2016 Aug; 67():130-8. PubMed ID: 27376460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells.
    Batran RZ; Kassem AF; Abbas EMH; Elseginy SA; Mounier MM
    Bioorg Med Chem; 2018 Jul; 26(12):3474-3490. PubMed ID: 29793751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.